Cargando…
A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: Impact of BRCA pathogenic variants
BACKGROUND: Better tools for post‐chemotherapy amenorrhea risk assessment are needed for fertility preservation decision‐making. Our aim was to determine the predictors of amenorrhea risk at 12 and 18 months post‐chemotherapy in women with breast cancer. METHODS: 142 women with breast cancer were lo...
Autores principales: | Oktay, Kutluk H., Turan, Volkan, Bedoschi, Giuliano, Abdo, Nadia, Bang, Heejung, Goldfarb, Shari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557848/ https://www.ncbi.nlm.nih.gov/pubmed/37698031 http://dx.doi.org/10.1002/cam4.6527 |
Ejemplares similares
-
Amenorrhea
Publicado: (1854) -
Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy
por: Shin, Jae Jun, et al.
Publicado: (2019) -
Editorial: Rising stars in reproduction: 2021
por: Bedoschi, Giuliano
Publicado: (2023) -
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
por: O’Mahony, Denise G., et al.
Publicado: (2023) -
Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise
por: Soleimani, Reza, et al.
Publicado: (2011)